ASTHMA SYMPTOM IMPROVEMENTS WITH BENRALIZUMAB ARE ASSOCIATED WITH IMPROVEMENTS IN ACTIVITY FUNCTIONS AND QUALITY OF LIFE FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
Pneumologie(2017)
Abstract
Benralizumab is a humanized, anti-eosinophilic monoclonal antibody that improves exacerbations and daily symptoms in patients (pts) with severe, uncontrolled eosinophilic asthma. This study investigated the association of asthma symptom improvements with activity impairment assessments and quality of life (QOL).
MoreTranslated text
Key words
benralizumab,uncontrolled asthma
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined